These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15667575)

  • 1. Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.
    Fliser D
    Eur J Clin Invest; 2005 Feb; 35(2):71-9. PubMed ID: 15667575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
    Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
    JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
    Monsalve E; Oviedo PJ; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
    Cardiovasc Res; 2007 Jan; 73(1):66-72. PubMed ID: 17097077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethylarginine dimethylaminohydrolase (DDAH)--a critical regulator of hypertensive left ventricular hypertrophy?
    Bai Y; Hui R
    Med Hypotheses; 2008; 70(5):962-6. PubMed ID: 17983707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
    Selley ML
    J Neurosci Res; 2004 Jul; 77(1):90-3. PubMed ID: 15197741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
    Tatematsu S; Wakino S; Kanda T; Homma K; Yoshioka K; Hasegawa K; Sugano N; Kimoto M; Saruta T; Hayashi K
    J Am Soc Nephrol; 2007 Mar; 18(3):741-9. PubMed ID: 17267746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.
    Okubo K; Hayashi K; Wakino S; Matsuda H; Kubota E; Honda M; Tokuyama H; Yamamoto T; Kajiya F; Saruta T
    Hypertens Res; 2005 Feb; 28(2):181-9. PubMed ID: 16025746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Asymmetric dimethylarginine: metabolism, arginine paradox, pathophysiology].
    Gilinskiĭ MA
    Usp Fiziol Nauk; 2007; 38(3):21-39. PubMed ID: 17977229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.
    Visser M; Paulus WJ; Vermeulen MA; Richir MC; Davids M; Wisselink W; de Mol BA; van Leeuwen PA
    Eur J Heart Fail; 2010 Dec; 12(12):1274-81. PubMed ID: 20923854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?
    Zoccali C; Kielstein JT
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):314-20. PubMed ID: 16609301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH
    Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
    Böger RH; Bode-Böger SM
    Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of asymmetric dimethylarginine.
    Siroen MP; Teerlink T; Nijveldt RJ; Prins HA; Richir MC; van Leeuwen PA
    Annu Rev Nutr; 2006; 26():203-28. PubMed ID: 16848705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.
    Weis M; Kledal TN; Lin KY; Panchal SN; Gao SZ; Valantine HA; Mocarski ES; Cooke JP
    Circulation; 2004 Feb; 109(4):500-5. PubMed ID: 14732750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine.
    Stühlinger MC; Tsao PS; Her JH; Kimoto M; Balint RF; Cooke JP
    Circulation; 2001 Nov; 104(21):2569-75. PubMed ID: 11714652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
    Böger RH
    Cardiovasc Res; 2003 Oct; 59(4):824-33. PubMed ID: 14553822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications.
    Yamagishi S; Ueda S; Nakamura K; Matsui T; Okuda S
    Curr Pharm Des; 2008; 14(25):2613-8. PubMed ID: 18991678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine, endothelial dysfunction and renal disease.
    Aldámiz-Echevarría L; Andrade F
    Int J Mol Sci; 2012; 13(9):11288-11311. PubMed ID: 23109853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.